Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Immunology

Differential T Helper Cell Responses to Human Papillomavirus Type 16 E7 Related to Viral Clearance or Persistence in Patients with Cervical Neoplasia: A Longitudinal Study

Tanja D. de Gruijl, Hetty J. Bontkes, Jan M. M. Walboomers, Marij J. Stukart, Fania S. Doekhie, Ans J. Remmink, Theo J. M. Helmerhorst, René H. M. Verheijen, Margaret F. Duggan-Keen, Peter L. Stern, Chris J. L. M. Meijer and Rik J. Scheper
Tanja D. de Gruijl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hetty J. Bontkes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan M. M. Walboomers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marij J. Stukart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fania S. Doekhie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ans J. Remmink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theo J. M. Helmerhorst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
René H. M. Verheijen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret F. Duggan-Keen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter L. Stern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris J. L. M. Meijer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rik J. Scheper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 1998
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

T-cell-mediated immune responses against oncogenic human papillomaviruses (HPVs) are believed to play a role in the prevention of cervical carcinogenesis. The in vitro production of interleukin 2 by CD4+ T helper (Th) cells in response to overlapping 20-mer peptides covering the HPV-16 E7 oncoprotein sequence was determined in 72 women with cytological evidence of premalignant cervical intraepithelial neoplasia (CIN) who participated in a nonintervention follow-up (FU) study. In addition, 15 HPV-16 + cervical carcinoma patients were tested. Positive Th cell reactivity was restricted to patients infected by HPV-16 and related types and showed a strong association with viral persistence and disease progression, as evidenced by the high frequency of positive responders among women with persistent HPV-16 infections who ended FU with high-grade CIN III lesions [14 of 15 (93%)]. Women with cervical carcinoma showed responses at a significantly reduced rate [7 of 15 (47%); P = 0.014]. Over the FU period (10–34 months), the level of E7-induced interleukin 2 production from the lymphocytes of CIN patients who had cleared HPV-16 infection showed an inverse correlation with time relative to the last positive HPV DNA test, with 8 of 13 of these patients showing positive responses after clearance. By contrast, among women with persistent HPV-16 infections and developing CIN III lesions (n = 8), there was a rise in Th cell activity over the course of FU. The majority of women responded to an immunogenic region in the carboxyl terminus of the E7 protein (amino acids 67–98). The observed HPV-16 E7-specific Th cell responses may develop as a consequence of increased antigen availability resulting either from clearance or from progression of cervical lesions.

Footnotes

  • ↵1 Supported by grants from the Prevention Fund (Grant 28-1502.2) and the University Stimulation Fund of the Free University to (T. D. d. G., H. J. B., J. M. M. W., M. J. S., A. J. R., T. J. M. H., C. J. L. M. M., and R. J. S.). M. F. D-K. and P. L. S. received financial support from the Cancer Research Campaign. P. L. S. was visiting professor of the Pasman Chair for Internatonalisation of the Oncology Research Institute of the Vrije Universiteit, Amsterdam.

  • ↵2 To whom correspondence should be addressed, at Department of Pathology, Free University Hospital, P. O. Box 7057, 1007 MB Amsterdam, the Netherlands. Phone: 31-20-4444070; Fax: 31-20-4442964; E-mail: pathol@azvu.nl.

  • Received December 19, 1997.
  • Accepted February 18, 1998.
  • ©1998 American Association for Cancer Research.
PreviousNext
Back to top
April 1998
Volume 58, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential T Helper Cell Responses to Human Papillomavirus Type 16 E7 Related to Viral Clearance or Persistence in Patients with Cervical Neoplasia: A Longitudinal Study
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Differential T Helper Cell Responses to Human Papillomavirus Type 16 E7 Related to Viral Clearance or Persistence in Patients with Cervical Neoplasia: A Longitudinal Study
Tanja D. de Gruijl, Hetty J. Bontkes, Jan M. M. Walboomers, Marij J. Stukart, Fania S. Doekhie, Ans J. Remmink, Theo J. M. Helmerhorst, René H. M. Verheijen, Margaret F. Duggan-Keen, Peter L. Stern, Chris J. L. M. Meijer and Rik J. Scheper
Cancer Res April 15 1998 (58) (8) 1700-1706;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differential T Helper Cell Responses to Human Papillomavirus Type 16 E7 Related to Viral Clearance or Persistence in Patients with Cervical Neoplasia: A Longitudinal Study
Tanja D. de Gruijl, Hetty J. Bontkes, Jan M. M. Walboomers, Marij J. Stukart, Fania S. Doekhie, Ans J. Remmink, Theo J. M. Helmerhorst, René H. M. Verheijen, Margaret F. Duggan-Keen, Peter L. Stern, Chris J. L. M. Meijer and Rik J. Scheper
Cancer Res April 15 1998 (58) (8) 1700-1706;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Immunology

  • Abstract 6595: Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells
  • Abstract 6711: Combinations of belantamab mafodotin with lenalidomide, pomalidomide, bortezomib and/or dexamethasone synergize in vitro and potentiate in vivo anti-tumor activity in multiple myeloma
  • Abstract 6593: PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer
Show more Immunology

Articles

  • Id Gene Expression as a Key Mediator of Tumor Cell Biology
  • Identification and Characterization of Collaborating Oncogenes in Compound Mutant Mice
  • Radiation Biology and Treatment Options in Radiation Oncology
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement